Investors Sell 515.3 Million Neimeth Shares

According to an announcement filed with the Nigerian Stock Exchange, Clinoscope Services Limited, a significant shareholder of Neimeth International Pharmaceuticals Plc, has sold a total of 515.3 million ordinary shares of the company.

The announcement indicates that the transaction involves the sale of Neimeth ordinary shares (ISIN: NGNEIMETH001) between September 17 and December 19, 2025. Lagos The announcement states that 15.3 million shares were sold at a price of 6.10 Nigerian Naira per share, and another 500 million shares were sold at a price of 6.00 Nigerian Naira per share. The total number of shares sold was 515.3 million, with an average price of 6.05 Nigerian Naira per share.

The announcement explicitly states that Clinoscope Services Limited is a significant shareholder of Neimeth International Pharmaceuticals Plc. This transaction is classified as an initial disclosure in accordance with market disclosure requirements.

Neimeth International Pharmaceuticals Plc, a publicly traded healthcare company, has notified the stock exchange of insider trading in accordance with post-trade transparency and corporate governance rules designed to promote market integrity and investor awareness.

The company stated that the announcement only involves the sale of shares by shareholders and has no impact on its daily operations.

Copyright. No material or other digital content on this website may be reproduced, published, transmitted, rewritten, or redistributed in any form or by any means without the prior express written permission of PidomNigeria.

Contact: